BDBM716335 N'-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]-N-(2-{2-[2-({2-methyl-8-[4-(trifluoromethyl)phenyl]-2H,8H-pyrazolo[3,4-b]indol-5-yl}formamido)ethoxy]ethoxy}ethyl)-3,6,9,12,15-pentaoxaheptadecanediamide (Compound 1)::US20250032625, Compound 1

SMILES Cn1cc2c3cc(C(=O)NCCOCCOCCNC(=O)COCCOCCOCCOCCOCC(=O)Nc4cccc5c4C(=O)N(C4CCC(=O)NC4=O)C5=O)ccc3n(-c3ccc(C(F)(F)F)cc3)c2n1

InChI Key InChIKey=JHKJTQLZJSZEHT-UHFFFAOYSA-N

Data  1 Kd

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 716335   

TargetTranscriptional enhancer factor TEF-1 [209-426](Human)
Merck Patent

US Patent
LigandPNGBDBM716335(N'-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihy...)
Affinity DataKd:  1.87E+3nMAssay Description:The kinetic and affinity parameters of protein-exemplary compound interactions were evaluated by SPR. hsTEAD1 (209-426) was immobilized onto a CM7 (S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2025
Entry Details
Go to US Patent